NMN, or nicotinamide mononucleotide, is a supplement that raises levels of NAD+ in your body, a molecule essential for energy production, DNA repair, and cellular maintenance. NAD+ levels naturally decline with age, dropping significantly by middle age, and NMN serves as a raw material your cells use to rebuild their supply. In human trials, daily NMN supplementation has roughly doubled blood NAD+ concentrations within two weeks.
How NMN Becomes NAD+ in Your Body
NMN is a small molecule built from nicotinamide riboside bonded to a phosphate group. It belongs to a family of compounds derived from vitamin B3, and your body already produces it naturally in small amounts. Once inside your cells, NMN feeds into what’s called the salvage pathway, a recycling system that breaks down and rebuilds NAD+ continuously throughout the day.
Your cells have a dedicated transporter protein (known as Slc12a8) that pulls NMN directly inside. This transporter depends on sodium to function and is particularly active in the gut. What’s interesting is that the gene controlling this transporter ramps up its activity when NAD+ levels drop, essentially opening the door wider when your cells need NAD+ most urgently.
What the Human Trials Show
Most NMN research shifted from animal models to human trials in the past few years, and the results are promising but still early. Here’s what the controlled studies have found so far.
NAD+ Levels
A randomized, placebo-controlled study of 65 healthy adults found that 1 gram of NMN daily for 14 days increased whole-blood NAD+ concentrations by approximately twofold, with an average increase of 43.1 µM compared to placebo. Notably, nicotinamide riboside (NR), another popular NAD+ precursor, produced a comparable increase of 49.4 µM at the same dose. Plain nicotinamide (basic vitamin B3) did not significantly raise NAD+ at all.
Insulin Sensitivity
One of the more striking findings came from a 10-week trial in postmenopausal women who were overweight or obese and prediabetic. NMN supplementation increased muscle insulin sensitivity by roughly 25%, measured by how efficiently muscles absorbed glucose from the bloodstream. The researchers compared this improvement to effects previously seen with significant weight loss. Liver and fat tissue insulin sensitivity did not change, suggesting NMN’s metabolic benefits may be tissue-specific.
Aerobic Performance
A double-blind study in amateur runners tested NMN over six weeks at varying doses. Runners taking NMN improved their ventilatory thresholds, the points during exercise where breathing shifts from comfortable to labored. Power output at both the first and second ventilatory thresholds increased in a dose-dependent pattern, meaning higher NMN doses produced larger gains. However, maximum oxygen uptake (VO2 max) itself did not change. In practical terms, NMN appeared to help runners sustain harder efforts for longer without hitting their ceiling faster.
Arterial Stiffness
A 12-week trial of 36 middle-aged adults taking 250 mg of NMN daily found a trend toward reduced arterial stiffness, with pulse wave velocity (a measure of how rigid your arteries are) decreasing by an average of 25.1 cm/s in the NMN group. The estimated biological age of blood vessels also dropped by about 2 years compared to placebo. Neither result reached statistical significance, though, meaning the study was too small to confirm the effect with confidence.
Dosage Ranges Tested in Studies
Human trials have used daily doses ranging from 250 mg to 1,000 mg. A large multicenter trial tested 300 mg, 600 mg, and 900 mg per day for 60 days and found all three doses raised blood NAD+ without safety concerns. Most supplement brands sell NMN in capsules of 250 mg to 500 mg, with many users taking 500 mg daily.
Splitting the dose may matter. One 12-week study that used 125 mg twice daily (morning and evening, totaling 250 mg) found significant NAD+ increases at 4, 8, and 12 weeks. After participants stopped supplementation, their NAD+ levels returned to baseline by week 16, which tells you NMN’s effects depend on continued use.
How NMN Compares to NR
NMN and nicotinamide riboside (NR) are the two most popular NAD+ precursors on the market, and people frequently ask which one works better. The head-to-head human trial published in Nature Metabolism found they raised NAD+ to comparable levels at 1 gram per day. The molecules are closely related structurally: NMN is essentially NR with an added phosphate group. Some researchers have suggested NMN may need to be converted to NR before crossing certain cell membranes, while others point to the dedicated NMN transporter as evidence it can enter cells intact. The practical difference for consumers, based on current evidence, appears minimal.
Safety Profile
Across multiple controlled trials, NMN supplementation up to 900 mg daily for 60 days has produced no significant adverse events. Blood panels, liver markers, and other clinical measures have remained within normal ranges. Longer-term safety data is still limited, with the longest published trial running 12 weeks. Side effects reported in trials have been mild and comparable to placebo groups.
FDA Regulatory Status
NMN’s legal status in the United States went through a notable reversal. The FDA initially determined in 2022 that NMN could not be sold as a dietary supplement because it was being investigated as a drug. This triggered significant pushback from the supplement industry. In September 2025, the FDA reversed that position, confirming that NMN can be legally marketed as a dietary supplement. The agency sent updated letters to companies that had previously submitted new dietary ingredient notifications, clearing the path for legitimate sale.
This regulatory shift means NMN is now widely available from supplement manufacturers, but it also means quality varies. Because dietary supplements are not subject to the same pre-market testing as pharmaceuticals, third-party testing certifications (like NSF or USP verification) are your best indicator that a product contains what it claims.
What NMN Won’t Do
NMN is often marketed as an anti-aging breakthrough, but the human evidence is narrower than the hype suggests. The clearest effects so far are raising blood NAD+ levels and improving muscle insulin sensitivity in a specific population (overweight, prediabetic postmenopausal women). The exercise and cardiovascular benefits are suggestive but not yet confirmed by large trials. No human study has demonstrated that NMN extends lifespan, reverses aging, or prevents age-related diseases. The animal data, particularly in mice, is far more dramatic than anything yet replicated in people.
NMN is a well-tolerated supplement with a plausible biological mechanism and early human data supporting a few specific benefits. It is not, based on current evidence, a proven longevity intervention.